ASTRAZEN

Astrazeneca Pharma India Share PriceAstraZeneca Pharma India

₹4,832.65
32.1 (0.67%)
As on 06 December, 2023 | 04:36 BSE: 506820 NSE: ASTRAZENISIN: INE203A01020

Astrazeneca Pharma India Performance

Day Range

  • Low 4,726.85
  • High 4,875.00
₹ 4,832.65

52 Week Range

  • Low 3,098.00
  • High 4,996.90
₹ 4,832.65
  • Open Price4,800.00
  • Previous Close4,800.55
  • Volume9296

Start SIP in AstraZeneca Pharma India

Start SIP

Astrazeneca Pharma India Share Price

  • Over 1 Month 3.58%
  • Over 3 Month 11.58%
  • Over 6 Month 39.93%
  • Over 1 Year 46.23%

Astrazeneca Pharma India Key Statistics

P/E Ratio 79.1
PEG Ratio 1.2
Market Cap Cr 12,082
Price to Book Ratio 20.5
EPS 50.5
Dividend 0.3
Relative Strength Index 63.4
Money Flow Index 68.96
MACD Signal 27.32
Average True Range 108.49

Astrazeneca Pharma India Investment Rating

  • Master Rating:
  • Astrazeneca Pharma India has an operating revenue of Rs. 1,141.05 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 13% is healthy, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 24% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 65 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

AstraZeneca Pharma India Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 311295285250236232232
Operating Expenses Qtr Cr 258228225213195204194
Operating Profit Qtr Cr 53676037412838
Depreciation Qtr Cr 4444354
Interest Qtr Cr 1000000
Tax Qtr Cr 21186101279
Net Profit Qtr Cr 52541729332028
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 1,029820
Operating Expenses Annual Cr 838719
Operating Profit Annual in Cr 16586
Depreciation Cr 1617
Interest Annual Cr 11
Tax Annual Cr 3521
Net Profit Annual Cr 9962
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 58101
Cash from Investing Activity Annual Cr 185
Cash from Financing Annual Activity Cr -24-9
Net Cash Flow Annual Cr 5296
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 589511
Fixed Assets Annual Cr 7077
Total Non Current Assets Annual Cr 149151
Total Current Assets Annual Cr 835706
Total Assets Annual Cr 985857
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 235205
ROE Annual % 1712
ROCE Annual % 2916
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1913
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Astrazeneca Pharma India Technicals

EMA & SMA

Current Price
₹4,832.65
32.1 (0.67%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹4,718.38
  • 50 Day
  • ₹4,614.76
  • 100 Day
  • ₹4,385.47
  • 200 Day
  • ₹4,044.44
  • 20 Day
  • ₹4,713.43
  • 50 Day
  • ₹4,662.81
  • 100 Day
  • ₹4,365.14
  • 200 Day
  • ₹3,871.74

Astrazeneca Pharma India Resistance and Support

PIVOT
₹4,811.5
Resistance
First Resistance 4,896.15
Second Resistance 4,959.65
Third Resistance 5,044.30
RSI 63.40
MFI 68.96
MACD Single Line 27.32
MACD 38.66
Support
First Resistance 4,748.00
Second Resistance 4,663.35
Third Resistance 4,599.85

Astrazeneca Pharma India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 9,732 547,717 56.28
Week 9,533 578,641 60.7
1 Month 11,212 529,213 47.2
6 Month 17,061 868,388 50.9

Astrazeneca Pharma India Result Highlights

AstraZeneca Pharma India Synopsis

NSE-Medical-Diversified

Astrazeneca Pharma I is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1002.97 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2023. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.
Market Cap 12,082
Sales 1,141
Shares in Float 0.63
No of funds 92
Yield 0.33
Book Value 20.52
U/D Vol ratio 1.1
LTDebt / Equity
Alpha 0.12
Beta 0.43

AstraZeneca Pharma India

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 75%75%75%75%
Mutual Funds 2.42%1.76%1.22%1.22%
Foreign Portfolio Investors 2.69%2.68%2.7%2.61%
Financial Institutions/ Banks
Individual Investors 17.44%18.12%18.46%18.56%
Others 2.45%2.44%2.62%2.61%

AstraZeneca Pharma India Management

Name Designation
Mr. Narayan K Seshadri Chairman & Ind.Director
Mr. Sanjeev Kumar Panchal Executive Director
Mr. Rajesh Marwaha Executive Director
Mr. Ankush Nandra Non Executive Director
Ms. Shilpa Shidhar Divekar Independent Director
Ms. Weiying Sarah Wang Non Executive Director
Ms. Revathy Ashok Independent Director

Astrazeneca Pharma India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Astrazeneca Pharma India Corporate Action

Date Purpose Remarks
2023-11-09 Quarterly Results
2023-08-14 Quarterly Results
2023-05-30 Audited Results & Dividend
2023-02-10 Quarterly Results
2022-11-11 Quarterly Results
Date Purpose Remarks
2023-07-14 FINAL Rs.16.00 per share(800%)Dividend
2022-07-08 FINAL Rs.8.00 per share(400%)Final Dividend
2021-08-20 INTERIM Rs.2.00 per share(100%)Interim Dividend

AstraZeneca Pharma India MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 37,319
ICICI Prudential Innovation Fund Regular Growth 2,383
Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
Quant Healthcare Fund Regular Growth 162
ICICI Prudential S&P BSE 500 ETF 128

AstraZeneca Pharma India FAQs

What is Share Price of AstraZeneca Pharma India ?

AstraZeneca Pharma India share price is ₹4,832 As on 06 December, 2023 | 04:22

What is the Market Cap of AstraZeneca Pharma India ?

The Market Cap of AstraZeneca Pharma India is ₹12081.6 Cr As on 06 December, 2023 | 04:22

What is the P/E ratio of AstraZeneca Pharma India ?

The P/E ratio of AstraZeneca Pharma India is 79.1 As on 06 December, 2023 | 04:22

What is the PB ratio of AstraZeneca Pharma India ?

The PB ratio of AstraZeneca Pharma India is 20.5 As on 06 December, 2023 | 04:22

Q2FY23